Tenon Medical, Inc. (TNON)

US — Healthcare Sector
Peers: AIMD  SSKN  NPCE  MOVE  TIVC  BBLG  INVO  MOTS    ASAPF  DYNT  AZYO  SGHT 

Automate Your Wheel Strategy on TNON

With Tiblio's Option Bot, you can configure your own wheel strategy including TNON - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TNON
  • Rev/Share 0.913
  • Book/Share 2.6066
  • PB 0.4143
  • Debt/Equity 0.0384
  • CurrentRatio 5.4624
  • ROIC -1.2022

 

  • MktCap 8197168.0
  • FreeCF/Share -2.8051
  • PFCF -0.8124
  • PE -0.2833
  • Debt/Assets 0.0269
  • DivYield 0
  • ROE -2.2508

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
TNON
Published: March 25, 2025 by: Accesswire
Sentiment: Neutral

LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,271,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00. In a concurrent private placement (the "Private Placement" and together with the registered offering, the …

Read More
image for news Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
TNON
Published: March 25, 2025 by: Accesswire
Sentiment: Neutral

LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 733,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00. In a concurrent private placement (the "Private Placement" and together with the registered offering, the …

Read More
image for news Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

About Tenon Medical, Inc. (TNON)

  • IPO Date 2022-04-27
  • Website https://www.tenonmed.com
  • Industry Medical - Devices
  • CEO Mr. Steven M. Foster
  • Employees 27

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.